Conditional Plasminogen Activator Inhibitor Type 1 Deletion in the Endothelial Compartment Has No Beneficial Effect on Radiation-Induced Whole-Lung Damage in Mice

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):972-982. doi: 10.1016/j.ijrobp.2017.07.007. Epub 2017 Jul 11.

Abstract

Purpose: To investigate whether the endothelial pool of plasminogen activator inhibitor type 1 (PAI-1) plays a role in the development of radiation-induced lung damage, as previously demonstrated in the intestine.

Methods and materials: Human lung microvascular endothelial cells were exposed to 10 Gy irradiation so as to study their ability to acquire an "activated" phenotype. Mice in which the Cre-Lox strategy was used to produce PAI-1 deletion specifically in the endothelial compartment were exposed to 17 Gy whole-thorax irradiation and followed up for 2, 13, and 23 weeks after irradiation.

Results: Human lung microvascular endothelial cells had an activated phenotype after radiation exposure, overexpressed PAI-1, and underwent endothelial-to-mesenchymal transition. In mice, knockout of PAI-1 in the endothelium had no beneficial effect on radiation-induced lung damage and showed a tendency to worsen acute lesions.

Conclusions: As opposed to the intestine, the endothelial pool of PAI-1 does not play a determinant role in the development of radiation-induced lung damage. The therapeutic value of PAI-1 inhibition in lung radiation injury may be associated with other types of cells.

MeSH terms

  • Animals
  • Cell Movement
  • Endothelium, Vascular / metabolism*
  • Endothelium, Vascular / radiation effects
  • Epithelial-Mesenchymal Transition*
  • Gene Knockout Techniques / methods
  • Humans
  • Lung / cytology
  • Lung / metabolism*
  • Lung / radiation effects*
  • Macrophages
  • Mice
  • Mice, Knockout
  • Neutrophils
  • Plasminogen Activator Inhibitor 1 / deficiency
  • Plasminogen Activator Inhibitor 1 / genetics
  • Plasminogen Activator Inhibitor 1 / metabolism*
  • Radiation Injuries, Experimental / etiology*
  • Radiation Injuries, Experimental / metabolism*
  • Real-Time Polymerase Chain Reaction

Substances

  • Plasminogen Activator Inhibitor 1